2024 Net Revenues of $4.77 billion, Up 6.5% (6.7% constant
currency)1,2
2024
Data-Tech-AI Net Revenues of $2.23
billion, Up
6.9%1,2,3,4
2024 Digital
Operations Net Revenues of $2.53
billion, Up 6.1% (6.5% constant
currency)1,4
2024 Diluted EPS of
$2.85, Down 16%; Adjusted Diluted EPS
of $3.28, Up
10%5,6
Increases
Quarterly Dividend by 11% and Share Repurchase Authorization by
$500 million
NEW
YORK, Feb. 6, 2025 /PRNewswire/ -- Genpact
Limited (NYSE: G), a global advanced technology services and
solutions company, today announced financial results for
the fourth quarter and full year ended December 31, 2024.

"We delivered another strong quarter to close out what has been
an outstanding year for Genpact. Q4 revenue grew 9% with
Data-Tech-AI up 12%, driving accelerating revenue growth. For the
full year, revenue grew 6.5%, with adjusted EPS growth of 10%,
consistent with our long-term objective of growing adjusted EPS
faster than revenue. We also delivered record new bookings of
$5.7 billion, up 15%, building on
exceptionally strong new bookings in 2023," said Balkrishan "BK"
Kalra, Genpact's President and CEO. "Looking ahead, we are
incredibly excited about the future as we accelerate the pace of
innovation and change at Genpact. Building on our industry-specific
domain expertise, our investment in Data, AI and Agentic Solutions
is positioning us as a clear leader in AI-driven transformation and
driving superior value for our clients."
Key Financial Highlights – Full Year 2024
- Net revenues were $4.77 billion,
up 6.5% year-over-year on an as reported basis, and 6.7% on a
constant currency basis.1,2
- Data-Tech-AI net revenues were $2.23
billion, up 6.9% year-over-year, both on an as reported and
constant currency basis,1,2,4 representing 47% of total
revenue.
- Digital Operations net revenues were $2.53 billion, up 6.1% year-over-year on an as
reported basis, and 6.5% on a constant currency
basis,1,4 representing 53% of total revenue.
- Gross profit was $1.69 billion,
up 8% year-over-year, with a corresponding margin of 35.5%.
- Net income was $514 million, down
19% year-over-year, with a corresponding margin of
10.8%.6
- Income from operations was $702
million, up 11% year-over-year, with a corresponding margin
of 14.7%.
- Adjusted income from operations was $814
million, up 7% year-over-year, with a corresponding margin
of 17.1%.6,7
- Diluted earnings per share was $2.85, down 16% year-over-year.6
- Adjusted diluted earnings per share was $3.28, up 10% year-over-year.5,6
- New bookings were approximately $5.7
billion, up 15% year-over-year.8
- Cash generated from operations was $615
million, up 25% year-over-year.
- Genpact repurchased approximately 7 million of its common
shares during the year for total consideration of approximately
$253 million at an average price per
share of $38.31.
Key Financial Highlights – Fourth Quarter 2024
- Net revenues were $1.25 billion,
up 8.9% year-over-year on an as reported basis and 8.7% on a
constant currency basis.1
- Data-Tech-AI net revenues were $595
million, up 11.9% year-over-year on an as reported basis,
and 11.7% on a constant currency basis,1,4 representing
48% of total revenue.
- Digital Operations net revenues were $654 million, up 6.4% year-over-year on an as
reported and 6.1% on a constant currency basis,1,4
representing 52% of total revenue.
- Gross profit was $446 million, up
9% year-over-year, with a corresponding margin of 35.7%.
- Net income was $142 million, down
51% year-over-year, with a corresponding margin of
11.4%.6
- Income from operations was $190
million, up 17% year-over-year, with a corresponding margin
of 15.2%.
- Adjusted income from operations was $221
million, up 9% year-over-year, with a corresponding margin
of 17.7%.6,7
- Diluted earnings per share was $0.79, down 50% year-over-year.6
- Adjusted diluted earnings per share was $0.91, up 11% year-over-year.5,6
- Cash generated from operations was $203
million, compared to $192
million in the fourth quarter of 2023.
- Genpact repurchased approximately 2 million of its common
shares during the quarter for total consideration of approximately
$85 million at an average price per
share of $45.41.
Capital Allocation
- Genpact's Board of Directors declared a quarterly cash dividend
for the first quarter of 2025 of $0.17 per common share, an 11% increase, payable
on March 26, 2025 to shareholders of
record as of the close of business on March
11, 2025, and approved a $500
million increase to the Company's existing share repurchase
authorization. The newly approved quarterly dividend represents a
planned annual dividend of $0.68 per
common share, increased from $0.61
per common share in 2024.
Outlook
Genpact's outlook for the full year 2025 is as follows:
- Net revenues in the range of $5.029
billion to $5.125 billion,
representing year-over-year growth of approximately 5.5% to 7.5% as
reported, or 6.2% to 8.2% on a constant currency basis.1
- Data-Tech-AI net revenues growth of approximately 6.2%
year-over-year and Digital Operations net revenues growth of
approximately 6.8% year-over-year as reported at the midpoint of
the range.
- Data-Tech-AI net revenues growth of approximately 6.4%
year-over-year and Digital Operations net revenues growth of
approximately 7.9% year-over-year on a constant currency
basis1 at the midpoint of the range.
- Gross margin of approximately 36.0%.
- Adjusted income from operations margin9 of
approximately 17.3%.
- Adjusted diluted EPS10 in the range of $3.52 to $3.59.
Genpact's outlook for the first quarter of 2025 is as
follows:
- Net revenues in the range of $1.202
billion to $1.213 billion,
representing year-over-year growth of approximately 6.2% to 7.2% as
reported, or 7.1% to 8.1% on a constant currency basis.1
- Data-Tech-AI net revenues growth of approximately 9.8%
year-over-year and Digital Operations net revenues growth of
approximately 4.1% year-over-year as reported at the midpoint of
the range.
- Data-Tech-AI net revenues growth of approximately 10.0%
year-over-year and Digital Operations net revenues growth of
approximately 5.4% year-over-year on a constant currency
basis1 at the midpoint of the range.
- Gross margin of approximately 35.0%.
- Adjusted income from operations margin9 of
approximately 16.5%.
- Adjusted diluted EPS10 in the range of $0.79 to $0.80.
Our outlook for the first quarter and full year 2025 reflects
foreign currency exchange rates as of January 30, 2025.
|
|
|
|
|
1 Revenue
growth on a constant currency basis is a non-GAAP measure and is
calculated by restating current-period activity using the prior
fiscal period's foreign currency exchange rates adjusted for
hedging gains/losses in such period.
|
2 Net
revenues and Data-Tech-AI net revenues for the full year 2023
include $0.5 million of revenue associated with a business
classified as held for sale.
|
3 Both on an
as reported and constant currency basis.
|
4 Genpact
updated the classification of certain revenues from Digital
Operations to Data-Tech-AI in the quarter ended March 31, 2024 to
more accurately reflect the nature of, and mode of delivery for,
the services provided, which have evolved over time. As a result,
the revenue from Digital Operations and Data-Tech-AI for the full
year 2023 originally reported was $2.48 billion and $1.99 billion,
respectively, which is $2.39 billion and $2.09 billion,
respectively, in accordance with the updated classification. The
numbers presented in this release for Data-Tech-AI net revenues and
Digital Operations net revenues may not add up precisely to the
total net revenues provided due to rounding.
|
5 Adjusted
diluted earnings per share is a non-GAAP measure. A reconciliation
of GAAP diluted earnings per share to adjusted diluted earnings per
share is attached to this release.
|
6 During the
quarter and full year ended December 31, 2023, Genpact completed an
intercompany transfer of certain intellectual property rights from
non-US to US wholly-owned subsidiaries, which resulted in a
non-recurring tax benefit of $170 million. Net income and diluted
earnings per share for the quarter and full year ended December 31,
2023 included this benefit. This benefit was excluded from adjusted
diluted earnings per share and adjusted income from operations for
the quarter and year ended December 31, 2023.
|
7 Adjusted
income from operations and adjusted income from operations margin
are non-GAAP measures. Reconciliations of each of GAAP income from
operations and GAAP net income to adjusted income from operations
and GAAP income from operations margin and GAAP net income margin
to adjusted income from operations margin are attached to this
release. Adjusted income from operations margin for the full year
2023 was derived by adjusting total revenue to exclude $0.5 million
of revenue associated with a business previously classified as held
for sale.
|
8 New
bookings, an operating measure, represents the total contract value
of new contracts and certain renewals, extensions and changes to
existing contracts. Regular renewals of contracts with no change in
scope are not counted as new bookings. Prior to 2024, new bookings
of contracts with longer than five-year terms were limited to the
total contract value of the initial five-year term. In 2024,
Genpact updated its definition of new bookings to eliminate the
five-year limitation. New bookings as reported for the full year
2023 were $4.9 billion and would have been $5.0 billion in
accordance with the new definition. New bookings for the full year
2024 as reported are $5.7 billion and would have been $5.4 billion
in accordance with the prior definition.
|
9 Adjusted
income from operations margin is a non-GAAP measure. A
reconciliation of the outlook for each of GAAP income from
operations margin and GAAP net income margin to adjusted income
from operations margin is attached to this release.
|
10 Adjusted
diluted earnings per share is a non-GAAP measure. A reconciliation
of the outlook for GAAP diluted earnings per share to adjusted
diluted earnings per share is attached to this release.
|
Conference Call to Discuss Financial Results
Genpact's management will host a conference call on February 6, 2025, at 5:00
PM ET to discuss the company's performance for the fourth
quarter and full year ended December 31,
2024. Participants are encouraged to register here to
receive a dial-in number and unique PIN for seamless access. It is
recommended to join 10 minutes before the call starts, although
registration and dial-in will be available at any time. A
live webcast will be available on the Genpact Investor Relations
website. For those unable to attend the live call, an archived
replay and transcript will be available on the website shortly
after the call.
About Genpact
Genpact (NYSE: G) is a global
professional services and solutions firm delivering outcomes that
shape the future. Our 125,000+ people across 30+ countries are
driven by our innate curiosity, entrepreneurial agility, and desire
to create lasting value for clients. Powered by our purpose – the
relentless pursuit of a world that works better for people – we
serve and transform leading enterprises, including the Fortune
Global 500, with our deep business and industry knowledge, digital
operations services, and expertise in data, technology, and AI.
Safe Harbor
This press release contains certain
statements concerning our future growth prospects, including our
outlook for 2025, financial results and other forward-looking
statements, as defined in the safe harbor provisions of the U.S.
Private Securities Litigation Reform Act of 1995. These statements
involve a number of risks, uncertainties and other factors that
could cause actual results to differ materially from those in such
forward-looking statements. These risks, uncertainties, and other
factors include but are not limited to general economic conditions,
any deterioration in the global economic environment and its impact
on our clients, our ability to develop and successfully execute our
business strategies, technological innovation, including AI
technology and future uses of agentic AI, generative AI and large
language models, and our ability to invest in new technologies and
adapt to industry developments at sufficient speed and scale, our
ability to effectively price our services and maintain pricing and
employee utilization rates, general inflationary pressures and our
ability to share increased costs with our clients, wage increases
in locations in which we have operations, our ability to attract
and retain skilled professionals, our ability to protect our and
our clients' data from security incidents or cyberattacks, the
economic and other impacts of geopolitical conflicts and any
related sanctions and other measures that have been or may be
implemented or imposed in response thereto, as well as any
potential expansion or escalation of existing conflicts or economic
disruption beyond their current scope, a slowdown in the economies
and sectors in which our clients operate, a slowdown in the sectors
in which we operate, the risks and uncertainties arising from our
past and future acquisitions, our ability to convert bookings to
revenues, our ability to manage growth, factors which may impact
our cost advantage, changes in tax rates and tax legislation and
other laws and regulations, our ability to effectively execute our
tax planning strategies, risks and uncertainties regarding
fluctuations in our earnings, foreign currency fluctuations,
political, economic or business conditions in countries in which we
operate, as well as other risks detailed in our reports filed with
the U.S. Securities and Exchange Commission, including Genpact's
Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
These filings are available at www.sec.gov. Genpact may from time
to time make additional written and oral forward-looking
statements, including statements contained in our filings with the
Securities and Exchange Commission and our reports to shareholders.
Although Genpact believes that these forward-looking statements are
based on reasonable assumptions, you are cautioned not to put undue
reliance on these forward-looking statements, which reflect
management's current analysis of future events and should not be
relied upon as representing management's expectations or beliefs as
of any date subsequent to the time they are made. Genpact
undertakes no obligation to update any forward-looking statements
that may be made from time to time by or on behalf of Genpact.
Contacts
|
|
|
|
|
|
Investors
|
|
Tyra Whelton
|
|
|
+1 (908)
418-2995
|
|
|
tyra.whelton@genpact.com
|
|
|
|
Media
|
|
Alexia
Taxiarchos
|
|
|
+1 (617)
259-8172
|
|
|
alexia.taxiarchos@genpact.com
|
GENPACT LIMITED AND
ITS SUBSIDIARIES
|
|
Consolidated Balance
Sheets
|
(Unaudited)
|
(In thousands,
except per share data and share count)
|
|
|
|
As of December 31,
2023
|
|
As of December 31,
2024
|
Assets
|
|
|
|
|
Current
assets
|
|
|
|
|
Cash and cash
equivalents
|
|
$
583,670
|
|
$
648,246
|
Short-term
investments
|
|
—
|
|
23,359
|
Accounts receivable,
net of allowance for credit losses of $18,278
and $12,094 as of December 31, 2023 and 2024,
respectively
|
|
1,116,273
|
|
1,198,606
|
Prepaid expenses and
other current assets
|
|
191,566
|
|
209,893
|
Total current
assets
|
|
$
1,891,509
|
|
$
2,080,104
|
|
|
|
|
|
Property, plant and
equipment, net
|
|
189,803
|
|
207,943
|
Operating lease
right-of-use assets
|
|
186,167
|
|
182,190
|
Deferred tax
assets
|
|
298,921
|
|
269,476
|
Intangible assets,
net
|
|
53,028
|
|
26,950
|
Goodwill
|
|
1,683,782
|
|
1,669,769
|
Contract cost
assets
|
|
202,543
|
|
200,900
|
Other assets, net of
allowance for credit losses of $4,096 and $7,320 as
of December 31, 2023 and December 31, 2024, respectively
|
|
299,960
|
|
349,821
|
Total
assets
|
|
$
4,805,713
|
|
$
4,987,153
|
|
|
|
|
|
Liabilities and
equity
|
|
|
|
|
Current
liabilities
|
|
|
|
|
Short-term
borrowings
|
|
$
10,000
|
|
$
—
|
Current portion of
long-term debt
|
|
432,242
|
|
26,173
|
Accounts
payable
|
|
27,739
|
|
36,469
|
Income taxes
payable
|
|
38,458
|
|
35,431
|
Accrued expenses and
other current liabilities
|
|
759,180
|
|
812,994
|
Operating leases
liability
|
|
50,313
|
|
52,672
|
Total current
liabilities
|
|
$
1,317,932
|
|
$
963,739
|
|
|
|
|
|
Long-term debt, less
current portion
|
|
824,720
|
|
1,195,267
|
Operating leases
liability
|
|
168,015
|
|
153,587
|
Deferred tax
liabilities
|
|
11,706
|
|
15,908
|
Other
liabilities
|
|
234,948
|
|
269,041
|
Total
liabilities
|
|
$
2,557,321
|
|
$
2,597,542
|
|
|
|
|
|
Shareholders'
equity
|
|
|
|
|
Preferred shares, $0.01
par value, 250,000,000 authorized, none issued
|
|
—
|
|
—
|
Common shares, $0.01
par value, 500,000,000 authorized, 179,494,132
and 174,661,953, issued and outstanding as of December 31, 2023
and
2024, respectively
|
|
1,789
|
|
1,740
|
Additional paid-in
capital
|
|
1,883,944
|
|
1,945,261
|
Retained
earnings
|
|
1,085,209
|
|
1,236,696
|
Accumulated other
comprehensive income (loss)
|
|
(722,550)
|
|
(794,086)
|
Total
equity
|
|
$
2,248,392
|
|
$
2,389,611
|
|
|
|
|
|
Total liabilities
and equity
|
|
$
4,805,713
|
|
$
4,987,153
|
GENPACT LIMITED AND
ITS SUBSIDIARIES
|
|
Consolidated
Statements of Income
|
(Unaudited)
|
(In thousands,
except per share data and share count)
|
|
|
|
Three months ended
December 31,
|
|
|
2022
|
|
2023
|
|
2024
|
Net revenues
|
|
$
1,102,545
|
|
$
1,146,253
|
|
$
1,248,741
|
Cost of
revenue
|
|
717,337
|
|
738,699
|
|
802,969
|
Gross
profit
|
|
$
385,208
|
|
$
407,554
|
|
$
445,772
|
Operating
expenses:
|
|
|
|
|
|
|
Selling, general and
administrative expenses
|
|
236,557
|
|
237,419
|
|
249,157
|
Amortization of
acquired intangible assets
|
|
9,862
|
|
7,454
|
|
6,496
|
Other operating
(income) expense, net
|
|
11,038
|
|
(51)
|
|
(55)
|
Income from
operations
|
|
$
127,751
|
|
$
162,732
|
|
$
190,174
|
Foreign exchange gains
(losses), net
|
|
6,080
|
|
576
|
|
(1,487)
|
Interest income
(expense), net
|
|
(15,513)
|
|
(12,915)
|
|
(11,047)
|
Other income (expense),
net
|
|
4,799
|
|
8,081
|
|
4,908
|
Income before income
tax expense
|
|
$
123,117
|
|
$
158,474
|
|
$
182,548
|
Income tax
expense/(benefit)
|
|
33,405
|
|
(132,835)
|
|
40,633
|
Net
income
|
|
$
89,712
|
|
$
291,309
|
|
$
141,915
|
Earnings per common
share
|
|
|
|
|
|
|
Basic
|
|
$
0.49
|
|
$
1.61
|
|
$
0.81
|
Diluted
|
|
$
0.48
|
|
$
1.59
|
|
$
0.79
|
Weighted average number
of common shares used in computing
earnings per common share
|
|
|
|
|
|
|
Basic
|
|
183,371,581
|
|
180,956,638
|
|
175,880,251
|
Diluted
|
|
187,525,698
|
|
183,354,187
|
|
179,183,557
|
GENPACT LIMITED AND
ITS SUBSIDIARIES
|
|
Consolidated
Statements of Income
|
(Unaudited)
|
(In thousands,
except per share data and share count)
|
|
|
|
Year ended December
31,
|
|
|
2022
|
|
2023
|
|
2024
|
Net revenues
|
|
$
4,371,172
|
|
$
4,476,888
|
|
$
4,767,139
|
Cost of
revenue
|
|
2,834,774
|
|
2,906,223
|
|
3,077,073
|
Gross
profit
|
|
$
1,536,398
|
|
$
1,570,665
|
|
$
1,690,066
|
Operating
expenses:
|
|
|
|
|
|
|
Selling, general and
administrative expenses
|
|
938,385
|
|
913,061
|
|
967,145
|
Amortization of
acquired intangible assets
|
|
42,667
|
|
31,463
|
|
26,476
|
Other operating
(income) expense, net
|
|
53,195
|
|
(4,716)
|
|
(5,616)
|
Income from
operations
|
|
$
502,151
|
|
$
630,857
|
|
$
702,061
|
Foreign exchange gains
(losses), net
|
|
15,392
|
|
4,274
|
|
2,937
|
Interest income
(expense), net
|
|
(52,204)
|
|
(47,935)
|
|
(47,214)
|
Other income (expense),
net
|
|
(103)
|
|
15,028
|
|
19,036
|
Income before income
tax expense
|
|
$
465,236
|
|
$
602,224
|
|
$
676,820
|
Income tax
expense/(benefit)
|
|
111,832
|
|
(29,031)
|
|
163,150
|
Net
income
|
|
$
353,404
|
|
$
631,255
|
|
$
513,670
|
Earnings per common
share
|
|
|
|
|
|
|
Basic
|
|
$
1.92
|
|
$
3.46
|
|
$
2.88
|
Diluted
|
|
$
1.88
|
|
$
3.41
|
|
$
2.85
|
Weighted average number
of common shares used in computing
earnings per common share
|
|
|
|
|
|
|
Basic
|
|
184,184,930
|
|
182,345,548
|
|
178,385,972
|
Diluted
|
|
188,087,240
|
|
185,141,843
|
|
180,436,900
|
GENPACT LIMITED AND
ITS SUBSIDIARIES
|
|
Consolidated
Statements of Cash Flows
|
(Unaudited)
|
(In
thousands)
|
|
|
|
Year ended December
31,
|
|
|
2022
|
|
2023
|
|
2024
|
Operating
activities
|
|
|
|
|
|
|
Net income
|
|
$
353,404
|
|
$
631,255
|
|
$
513,670
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
86,849
|
|
72,530
|
|
69,778
|
Amortization of debt
issuance costs (including loss on extinguishment of
debt)
|
|
2,376
|
|
1,967
|
|
2,412
|
Amortization of
acquired intangible assets
|
|
42,667
|
|
31,463
|
|
26,476
|
Write-down of
intangible assets and property, plant and equipment
|
|
1,377
|
|
—
|
|
—
|
Impairment charge on
assets classified as held for sale
|
|
32,575
|
|
—
|
|
—
|
Loss on sale of
business classified as held for sale
|
|
—
|
|
802
|
|
—
|
Write-down of operating
lease right-of-use assets and other assets
|
|
20,307
|
|
—
|
|
—
|
Allowance for credit
losses
|
|
1,583
|
|
3,979
|
|
13,806
|
Unrealized loss/(gain)
on revaluation of foreign currency asset/liability
|
|
525
|
|
(1,061)
|
|
(11,354)
|
Stock-based
compensation expense
|
|
77,373
|
|
88,576
|
|
66,383
|
Deferred tax expense
(benefit)
|
|
(29,151)
|
|
(157,932)
|
|
36,610
|
Others, net
|
|
863
|
|
1,477
|
|
(2,179)
|
Change in operating
assets and liabilities:
|
|
|
|
|
|
|
(Increase) in accounts
receivable
|
|
(112,341)
|
|
(130,791)
|
|
(96,555)
|
(Increase) decrease in
prepaid expenses, other current assets, contract cost assets,
operating lease right-of-use assets and other assets
|
|
3,822
|
|
(39,075)
|
|
(73,512)
|
Increase (decrease) in
accounts payable
|
|
14,185
|
|
(8,215)
|
|
8,733
|
Increase (decrease) in
accrued expenses, other current liabilities, operating lease
liabilities and other liability
|
|
(54,329)
|
|
1,862
|
|
63,340
|
Increase (decrease) in
income taxes payable
|
|
1,585
|
|
(6,025)
|
|
(2,184)
|
Net cash provided by
operating activities
|
|
$
443,670
|
|
$
490,812
|
|
$
615,424
|
Investing
activities
|
|
|
|
|
|
|
Purchase of property,
plant and equipment
|
|
(50,614)
|
|
(55,421)
|
|
(82,766)
|
Payment for internally
generated intangible assets (including intangibles under
development)
|
|
(3,775)
|
|
(3,356)
|
|
(2,469)
|
Purchase of short term
investments
|
|
—
|
—
|
—
|
|
(23,359)
|
Proceeds from sale of
property, plant and equipment and intangible assets
|
|
60
|
|
25
|
|
2,635
|
Payment for business
acquisitions, net of cash acquired
|
|
(33)
|
|
(682)
|
|
—
|
Proceeds from /
(payment) for divestiture of business
|
|
17,769
|
|
(19,510)
|
|
—
|
Net cash used for
investing activities
|
|
$
(36,593)
|
|
$
(78,944)
|
|
$
(105,959)
|
Financing
activities
|
|
|
|
|
|
|
Repayment of finance
lease obligations
|
|
(12,810)
|
|
(12,165)
|
|
(11,358)
|
Payment of debt
issuance costs
|
|
(3,045)
|
|
—
|
|
(4,165)
|
Proceeds from long-term
debt
|
|
239,130
|
|
—
|
|
400,000
|
Repayment of long-term
debt
|
|
(620,130)
|
|
(19,875)
|
|
(433,125)
|
Proceeds from
short-term borrowings
|
|
261,000
|
|
148,000
|
|
50,000
|
Repayment of short-term
borrowings
|
|
(110,000)
|
|
(289,000)
|
|
(60,000)
|
Proceeds from issuance
of common shares under stock-based compensation plans
|
|
27,751
|
|
39,485
|
|
17,215
|
Payment for net
settlement of stock-based awards
|
|
(44,942)
|
|
(21,529)
|
|
(22,278)
|
Payment of earn-out
consideration
|
|
(2,437)
|
|
(2,399)
|
|
—
|
Dividend
paid
|
|
(91,837)
|
|
(100,014)
|
|
(108,466)
|
Payment for stock
repurchased and retired (including expenses related to stock
repurchased)
|
|
(214,082)
|
|
(225,499)
|
|
(252,671)
|
Net cash used for
financing activities
|
|
$
(571,402)
|
|
$
(482,996)
|
|
$
(424,848)
|
Effect of exchange rate
changes
|
|
(88,368)
|
|
8,033
|
|
(20,041)
|
Net increase (decrease)
in cash and cash equivalents
|
|
(164,325)
|
|
(71,128)
|
|
84,617
|
Cash and cash
equivalents at the beginning of the period
|
|
899,458
|
|
646,765
|
|
583,670
|
Cash and cash
equivalents at the end of the period
|
|
$
646,765
|
|
$
583,670
|
|
$
648,246
|
Supplementary
information
|
|
|
|
|
|
|
Cash paid during the
period for interest (including interest rate swaps)
|
|
$
51,147
|
|
$
47,989
|
|
$
68,913
|
Cash paid during the
period for income taxes, net of refunds
|
|
$
145,979
|
|
$
156,733
|
|
$
113,629
|
Property, plant and
equipment acquired under finance lease obligations
|
|
$
7,078
|
|
$
2,459
|
|
$
11,483
|
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented
in accordance with GAAP, this press release includes the following
non-GAAP financial measures:
- Adjusted income from operations;
- Adjusted income from operations margin;
- Adjusted diluted earnings per share; and
- Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any
comprehensive set of accounting rules or principles and should not
be considered a substitute for, or superior to, financial measures
calculated in accordance with GAAP, and may be different from
non-GAAP financial measures used by other companies. Accordingly,
these non-GAAP financial measures, the financial statements
prepared in accordance with GAAP and the reconciliations of
Genpact's GAAP financial statements to such non-GAAP financial
measures should be carefully evaluated.
Given Genpact's acquisitions of varying scale and size, and
the difficulty in predicting expenses relating to acquisitions and
the amortization of acquired intangibles thereof, since
July 2012 Genpact's management has
used financial statements that exclude all acquisition-related
expenses and amortization of acquired intangibles for its internal
management reporting, budgeting and decision-making purposes,
including comparing Genpact's operating results to those of its
competitors. For the same reasons, since April 2016, Genpact's management has excluded the
impairment of acquired intangible assets from the financial
statements it uses for internal management purposes.
Acquisition-related expenses are excluded in the period in which an
acquisition is consummated. Genpact's management also uses
financial statements that exclude stock-based compensation expense.
Because of varying available valuation methodologies, subjective
assumptions and the variety of award types that companies can use
when adopting ASC 718 "Compensation-Stock Compensation," Genpact's
management believes that providing non-GAAP financial measures that
exclude such expenses allows investors to make additional
comparisons between Genpact's operating results and those of other
companies.
During the second quarter of 2022, Genpact approved a plan to
divest a business that was no longer deemed strategic. Given the
specialized nature of this business, we anticipated completing a
transaction within twelve months after the end of the second
quarter of 2022, and therefore, we classified the revenues and
expenses related to this business as held for sale with effect from
April 1, 2022. During the first
quarter of 2023, the Company consummated this transaction and
recorded a loss on the sale of the business. During the second
quarter of 2023, the Company terminated a lease for office property
which was fully impaired as part of a restructuring in the second
quarter of 2022 and recorded a gain on such lease termination as
restructuring income in the second quarter of 2023. During the
fourth quarter of 2023, Genpact completed an intercompany transfer
of certain intellectual property rights from non-US to US
wholly-owned subsidiaries, which resulted in a non-recurring tax
benefit of $170 million. Genpact's
management believes that excluding the loss on the sale of the
business previously classified as held for sale, the revenues and
expenses associated with such business, the gain on the lease
termination and the non-recurring tax benefit on the transfer of
intellectual property rights in calculating its non-GAAP financial
measures provides useful information to both management and
investors regarding the Company's financial performance and
underlying business trends. Additionally, in its calculations of
non-GAAP financial measures, Genpact's management has adjusted
foreign exchange gains and losses, interest income and expense and
income tax expenses from GAAP net income, and other income and
expenses, and certain gains from GAAP income from operations,
because management believes that the Company's results after taking
into account these adjustments more accurately reflect the
Company's ongoing operations. In its calculations of adjusted
diluted earnings per share, Genpact's management adds back
stock-based compensation expense, amortization and impairment of
acquired intangible assets, and acquisition-related expenses along
with the related tax impact of other adjustments and excludes the
non-recurring tax benefit on the transfer of intellectual property
rights from GAAP diluted earnings per share. For the purpose of
calculating adjusted diluted earnings per share, the combined
current and deferred tax effect is determined by multiplying each
pre-tax adjustment by the applicable statutory income tax
rate.
Genpact's management provides information about revenues on a
constant currency basis so that the revenues may be viewed without
the impact of foreign currency exchange rate fluctuations compared
to prior fiscal periods, thereby facilitating period-to-period
comparisons of the Company's true business performance. Revenue
growth on a constant currency basis is calculated by restating
current-period activity using the prior fiscal period's foreign
currency exchange rates adjusted for hedging gains/losses in such
period.
Accordingly, Genpact believes that the presentation of
adjusted income from operations, adjusted income from operations
margin, adjusted diluted earnings per share and revenue growth on a
constant currency basis, when read in conjunction with the
Company's reported results, can provide useful supplemental
information to investors and management regarding financial and
business trends relating to its financial condition and results of
operations.
A limitation of using adjusted income from operations and
adjusted income from operations margin versus income from
operations, income from operations margin, net income and net
income margin calculated in accordance with GAAP is that these
non-GAAP financial measures exclude certain recurring costs and
certain other charges, namely stock-based compensation expense and
amortization and impairment of acquired intangible assets.
Management compensates for this limitation by providing specific
information on the GAAP amounts excluded from adjusted income from
operations and adjusted income from operations margin.
The following tables show the reconciliation of these non-GAAP
financial measures to the most directly comparable GAAP measures
for the three months and years ended December 31, 2023 and 2024:
Reconciliation of
Net Income/Margin to Adjusted Income from
Operations/Margin
|
(In
thousands)
|
|
|
|
Three months
ended
December 31,
|
|
Year ended
December 31,
|
|
|
2023
|
|
2024
|
|
2023
|
|
2024
|
Net income
|
|
$ 291,309
|
|
$
141,915
|
|
$ 631,255
|
|
$ 513,670
|
Foreign exchange
(gains) losses, net
|
|
(576)
|
|
1,487
|
|
(4,274)
|
|
(2,937)
|
Interest (income)
expense, net
|
|
12,915
|
|
11,047
|
|
47,935
|
|
47,214
|
Income tax expense
/(benefit)
|
|
(132,835)
|
|
40,633
|
|
(29,031)
|
|
163,150
|
Stock-based
compensation expense
|
|
24,726
|
|
19,107
|
|
88,576
|
|
66,383
|
Amortization and
impairment of acquired intangible assets
|
|
7,453
|
|
6,493
|
|
31,348
|
|
26,456
|
Restructuring (income)
expense
|
|
—
|
|
—
|
|
(4,874)
|
|
—
|
Operating loss from
the business classified as held for sale
|
|
—
|
|
—
|
|
1,201
|
|
—
|
Loss on the sale of
business classified as held for sale
|
|
—
|
|
—
|
|
802
|
|
—
|
Adjusted income from
operations
|
|
$
202,992
|
|
$
220,682
|
|
$
762,938
|
|
$
813,936
|
Net income
margin
|
|
25.4 %
|
|
11.4 %
|
|
14.1 %
|
|
10.8 %
|
Adjusted income from
operations margin
|
|
17.7 %
|
|
17.7 %
|
|
17.0 %
|
|
17.1 %
|
Reconciliation of
Income from Operations/Margin to Adjusted Income from
Operations/Margin
|
(In
thousands)
|
|
|
|
Three
months ended
December 31,
|
|
Year ended
December 31,
|
|
|
2023
|
|
2024
|
|
2023
|
|
2024
|
Income from
operations
|
|
$ 162,732
|
|
$
190,174
|
|
$ 630,857
|
|
$ 702,061
|
Stock-based
compensation expense
|
|
24,726
|
|
19,107
|
|
88,576
|
|
66,383
|
Amortization and
impairment of acquired intangible assets
|
|
7,453
|
|
6,493
|
|
31,348
|
|
26,456
|
Other income
(expense), net
|
|
8,081
|
|
4,908
|
|
15,028
|
|
19,036
|
Restructuring (income)
expense
|
|
—
|
|
—
|
|
(4,874)
|
|
—
|
Operating loss from
the business classified as held for sale
|
|
—
|
|
—
|
|
1,201
|
|
—
|
Loss on the sale of
business classified as held for sale
|
|
—
|
|
—
|
|
802
|
|
—
|
Adjusted income from
operations
|
|
$
202,992
|
|
$
220,682
|
|
$
762,938
|
|
$
813,936
|
Income from operations
margin
|
|
14.2 %
|
|
15.2 %
|
|
14.1 %
|
|
14.7 %
|
Adjusted income from
operations margin
|
|
17.7 %
|
|
17.7 %
|
|
17.0 %
|
|
17.1 %
|
Reconciliation of
Diluted EPS to Adjusted Diluted EPS11
|
(Per share
data)
|
|
|
|
Three months
ended
December 31,
|
|
Year ended
December 31,
|
|
|
2023
|
|
2024
|
|
2023
|
|
2024
|
Diluted EPS
|
|
$
1.59
|
|
$
0.79
|
|
$
3.41
|
|
$
2.85
|
Stock-based
compensation expense
|
|
0.13
|
|
0.11
|
|
0.48
|
|
0.37
|
Amortization and
impairment of acquired intangible assets
|
|
0.04
|
|
0.04
|
|
0.17
|
|
0.15
|
Restructuring (income)
expense
|
|
—
|
|
—
|
|
(0.03)
|
|
—
|
Operating loss from
the business classified as held for sale
|
|
—
|
|
—
|
|
0.01
|
|
—
|
Loss on the sale of
business classified as held for sale
|
|
—
|
|
—
|
|
0.00
|
|
—
|
Tax impact on
stock-based compensation expense
|
|
(0.01)
|
|
(0.02)
|
|
(0.10)
|
|
(0.05)
|
Tax impact on
amortization and impairment of acquired intangible
assets
|
|
(0.01)
|
|
(0.01)
|
|
(0.04)
|
|
(0.04)
|
Tax impact on
restructuring (income) expense
|
|
—
|
|
—
|
|
0.01
|
|
—
|
Tax impact on
operating loss from the business classified as held for
sale
|
|
—
|
|
—
|
|
—
|
|
—
|
Tax benefit on
intercompany transfer of intellectual property rights
|
|
(0.93)
|
|
—
|
|
(0.92)
|
|
—
|
Adjusted diluted
EPS
|
|
$
0.82
|
|
$
0.91
|
|
$
2.98
|
|
$
3.28
|
|
|
|
|
|
11 Due to
rounding, the numbers presented in this table may not add up
precisely to the totals provided.
|
The following tables show the reconciliation of forward-looking
non-GAAP financial measures to the most directly comparable GAAP
measures for the year ending December 31,
2025:
Reconciliation of
Outlook for Net Income Margin to Adjusted Income from Operations
Margin12
|
|
|
|
Year ending December
31, 2025
|
Net income
margin
|
|
10.7 %
|
Estimated interest
(income) expense, net
|
|
1.0 %
|
Estimated income tax
expense
|
|
3.5 %
|
Estimated stock-based
compensation expense
|
|
1.6 %
|
Estimated amortization
and impairment of acquired intangible assets
|
|
0.5 %
|
Adjusted income from
operations margin
|
|
17.3 %
|
Reconciliation of
Outlook for Income from Operations Margin to Adjusted Income
from
|
Operations
Margin12
|
|
|
|
Year ending December
31, 2025
|
Income from
operations margin
|
|
14.9 %
|
Estimated stock-based
compensation expense
|
|
1.6 %
|
Estimated amortization
and impairment of acquired intangible assets
|
|
0.5 %
|
Estimated other income
(expense), net
|
|
0.3 %
|
Adjusted income from
operations margin
|
|
17.3 %
|
Reconciliation of
Outlook for Diluted EPS to Adjusted Diluted EPS12
|
(Per share
data)
|
|
|
|
Year ending December
31, 2025
|
|
|
Lower
|
|
Upper
|
Diluted
EPS
|
|
$
3.04
|
|
$
3.11
|
Estimated stock-based
compensation expense
|
|
0.46
|
|
0.46
|
Estimated amortization
and impairment of acquired intangible assets
|
|
0.15
|
|
0.15
|
Estimated tax impact
on stock-based compensation expense
|
|
(0.08)
|
|
(0.08)
|
Estimated tax impact
on amortization and impairment of acquired intangible
assets
|
|
(0.04)
|
|
(0.04)
|
Adjusted diluted
EPS
|
|
$
3.52
|
|
$
3.59
|
|
|
|
|
|
12 Due to
rounding, the numbers presented in this table may not add up
precisely to the totals provided.
|
The following tables show the reconciliation of forward-looking
non-GAAP financial measures to the most directly comparable GAAP
measures for the quarter ending March 31,
2025:
Reconciliation of
Outlook for Net Income Margin to Adjusted Income from Operations
Margin13
|
|
|
|
Quarter ending March
31, 2025
|
Net income
margin
|
|
10.1 %
|
Estimated interest
(income) expense, net
|
|
1.1 %
|
Estimated income tax
expense
|
|
3.3 %
|
Estimated stock-based
compensation expense
|
|
1.5 %
|
Estimated amortization
and impairment of acquired intangible assets
|
|
0.5 %
|
Adjusted income from
operations margin
|
|
16.5 %
|
Reconciliation of
Outlook for Income from Operations Margin to Adjusted Income
from
|
Operations
Margin13
|
|
|
|
Quarter ending March
31, 2025
|
Income from
operations margin
|
|
14.1 %
|
Estimated stock-based
compensation expense
|
|
1.5 %
|
Estimated amortization
and impairment of acquired intangible assets
|
|
0.5 %
|
Estimated other income
(expense), net
|
|
0.3 %
|
Adjusted income from
operations margin
|
|
16.5 %
|
Reconciliation of
Outlook for Diluted EPS to Adjusted Diluted EPS13
|
(Per share
data)
|
|
|
|
Quarter ending March
31, 2025
|
|
|
Lower
|
|
Upper
|
Diluted
EPS
|
|
$
0.68
|
|
$
0.69
|
Estimated stock-based
compensation expense
|
|
0.10
|
|
0.10
|
Estimated amortization
and impairment of acquired intangible assets
|
|
0.04
|
|
0.04
|
Estimated tax impact
on stock-based compensation expense
|
|
(0.02)
|
|
(0.02)
|
Estimated tax impact
on amortization and impairment of acquired intangible
assets
|
|
(0.01)
|
|
(0.01)
|
Adjusted diluted
EPS
|
|
$
0.79
|
|
$
0.80
|
|
|
|
|
|
13 Due to
rounding, the numbers presented in this table may not add up
precisely to the totals provided.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/genpact-reports-full-year-and-fourth-quarter-2024-results-302370628.html
SOURCE Genpact